Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists

  title={Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists},
  author={Maja Tippmann-Peikert and J G Park and B F Boeve and John W. Shepard and M H Silber},
  pages={301 - 303}
Pathologic gambling is an impulse control disorder previously reported to complicate dopamine agonist therapy in patients with Parkinson disease. It has not been described in association with dopamine agonist therapy of other conditions. We report three patients treated in our sleep disorders center who developed pathologic gambling while receiving treatment with dopamine agonists for restless legs syndrome. 

Figures from this paper

Pathological gambling plus hypersexuality in restless legs syndrome: a new case
This report reports a new case with pathological gambling plus hypersexuality and impotence in an old patient treated with a small dose of pramipexole for restless legs syndrome for 5 months, confirming that restless legs Syndrome patients should be cautioned about potential dopamine dysregulation syndrome coinciding with dopaminergic agonists, as it can be reversed by drug withdrawal.
Drug-induced impulse control disorders in Parkinson’s disease
Dopamine replacement treatment with excessive or aberrant dopamine receptor stimulation can cause behavioral disturbances in Parkinson’s disease, comprising dopamine dysregulation syndrome, punding,
Anhedonia in Japanese patients with Parkinson's disease
This study examined hedonic tone in patients with PD using the Snaith–Hamilton Pleasure Scale (SHAPS) and investigated the associations with depressive mood by the Self‐Rating Questionnaire for Depression (SRQ‐D).
Impulse Control and Related Disorders in Parkinson's Disease
Current knowledge regarding these behavioral disorders, including phenomenology, epidemiology, pathophysiology, and treatment, are summarized.
Restless legs syndrome: clinical presentation diagnosis and treatment.
[Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Patients with PD or RLS should be informed that DAs use may lead to the development of impulsive and compulsive disorders, and clinicians should include the investigation of these disorders as part of routine clinical care.
The Emergence of Devastating Impulse Control Disorders During Dopamine Agonist Therapy of the Restless Legs Syndrome
This group of Australian RLS patients with ICDs display high levels of impulsivity and is the first to use the BIS-11 questionnaire in this setting, and needs careful consideration in light of their potentially devastating financial, social, and marital consequences.
Management of impulse control disorders in Parkinson’s disease
Approaches worth considering in the management of the PD patient with an ICD include reduction or discontinuation of dopamine agonist therapy, trials of various pharmacologic agents, psychosocial interventions, and deep brain stimulation of the subthalamic nucleus.
Compulsive habits in restless legs syndrome patients under dopaminergic treatment


Pathological gambling in two patients on dopamine replacement therapy for Parkinson’s disease
Abstract.We describe two cases where increases in dopaminergic therapy were initiated by the patients due to perceived deterioration in symptoms of idiopathic Parkinson’s disease. Shortly afterwards,
Pathologic gambling in patients with Parkinson's disease.
The most likely explanation for this newly recognized behavioral disorder in patients with Parkinson's disease is enhanced novelty seeking as a consequence of overstimulation of mesolimbic dopamine receptors resulting from addiction to dopaminergic drugs.
Pathological gambling caused by drugs used to treat Parkinson disease.
Dopamine agonist therapy was associated with potentially reversible pathological gambling, and pramipexole was the medication predominantly implicated.
Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease
A retrospective database review of all patients with PD seen at the Muhammad Ali Parkinson Research Center from May 1, 1999, to April 30, 2000, was performed for pathologic gambling, which revealed nine patients with pathological gambling associated with chronic high dose dopamine agonist (DA) therapy.
Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment?
The gambling behavior appears more often in the “on” periods of motor fluctuations and it begins after the onset of Parkinson's disease in most patients and worsens with levodopa therapy suggest that it could be related to the dopaminergic tone in patients with Parkinson’s disease and motor fluctuations.
Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.
Pramipexoles' demonstrated clinical efficacy for successful treatment in early disease for several years and as adjunctive therapy with L-dopa in late disease suggests a potential new paradigm for treatment of Parkinson's disease whereby new patients are initiated with pramipexole therapy and L-Dopa is added only as necessary.
Pharmacology of Pramipexole, a Dopamine D3-Preferring Agonist Useful in Treating Parkinson's Disease
  • M. Piercey
  • Biology, Psychology
    Clinical neuropharmacology
  • 1998
Pramipexole's demonstrated clinical efficacy for successful treatment in early disease for several years and as adjunctive therapy with L-dopa in late disease suggests a potential new paradigm for treatment of Parkinson's disease whereby new patients are initiated with pramipexoles therapy and L-Dopa is added only as necessary.
Updating and Refining Prevalence Estimates of Disordered Gambling Behaviour in the United States and Canada
  • H. Shaffer, M. Hall
  • Medicine
    Canadian journal of public health = Revue canadienne de sante publique
  • 2001
Membership in youth, treatment, and prison population segments is significantly associated with experiencing gambling-related disorders and understanding sub-clinical gamblers provides a meaningful opportunity to lower the public health burden associated with gambling disorders.
Jugular Bulb Diverticula: Clinical and Radiologic Aspects
A relationship between the extension of jugular diverticulum and clinical symptoms is revealed, however, this relationship lacks statistical evidence because of the limited number of patients.
Determination of Daily Variations of Brain 5‐Hydroxytryptamine and Dopamine Turnovers and of the Clearance of Their Acidic Metabolites in Conscious Rats by Repeated Sampling of Cerebrospinal Fluid
The turnovers of both transmitters and the clearances of their acid metabolites from the brain were shown to be significantly greater during the dark (red light) period than during the white light period.